z-logo
open-access-imgOpen Access
Novel HIV-1 Non-nucleoside Reverse Transcriptase Inhibitor Agents: Optimization of Diarylanilines with High Potency against Wild-Type and Rilpivirine-Resistant E138K Mutant Virus
Author(s) -
Na Liu,
Wei Lei,
Li Huang,
F. Richard Yu,
Weifan Zheng,
Bingjie Qin,
Dongqin Zhu,
Susan L. MorrisNatschke,
Shibo Jiang,
Chin-Ho Chen,
KuoHsiung Lee,
Lan Xie
Publication year - 2016
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/50ct-kq06
Subject(s) - rilpivirine , reverse transcriptase , virology , nucleoside reverse transcriptase inhibitor , mutant , potency , reverse transcriptase inhibitor , wild type , human immunodeficiency virus (hiv) , chemistry , biology , in vitro , polymerase chain reaction , viral load , biochemistry , gene , antiretroviral therapy

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom